Business Club January 24th
Last year, the Beijing biopharmaceutical industry realized sales revenue of 55.95 billion yuan, of which biomedical manufacturing industry realized sales revenue of 48.35 billion yuan, and R&D service industry completed income of 7.6 billion yuan. Yesterday, the reporter learned from the Beijing Municipal Science and Technology Commission that at present, 39 G20 (Beijing biomedical industry leap-forward development projects) enterprises have become the core strength of the Beijing biopharmaceutical industry, achieving sales revenue of 24.72 billion yuan from January to November last year alone. It accounts for nearly half of the total industry.
Last year was the year in which Beijing's biopharmaceutical industry straddles development projects. After nearly one year's efforts, the city's biopharmaceutical industry successfully completed its first year's target. At present, the bio-pharmaceutical industry has become an important part of Beijing's economy. Last year alone, the pharmaceutical manufacturing industry achieved an industrial added value of 11.86 billion yuan, ranking fifth in the city's 36 industrial sectors.
In addition, chemical and pharmaceuticals accounted for half of all sub-sectors, and continued to maintain rapid growth. Its main business revenue growth rate of 22%, total profit growth rate of 31%. Among them, the contribution of the Chinese medicine industry has become increasingly prominent. Its total profit growth rate has increased from 4% in 2007 to 20.8% in 2010. Biopharmaceuticals have entered a stage of rapid development, and the main business income has experienced a compound annual growth rate since 2007. It reached 25.1%, and the total annual growth rate of its profit exceeded 41%. Its contribution to the pharmaceutical industry in Beijing has increased year by year, accounting for 21.4% of profits. The contribution in the medical device field has remained stable. The main business income and profits have all accounted for Beijing Pharmaceutical Industry. One-fifth.
As one of the highlights of this project, the Municipal Science and Technology Commission has been committed to docking major national projects and winning major national achievements, projects, and bases in Beijing. Last year, it also won great success in docking the country's "great new drug creation" major science and technology work. According to Yan Aoshuang, director of the Municipal Science and Technology Commission, as of now, the city has undertaken a total of 275 major special projects of science and technology for the country's "major new drug creation" project, and has received funding of 1.81 billion yuan, accounting for 32.9% of the total special funds. At the same time, the city has also successfully implemented two major base projects of “Beijing Bio-pharmaceutical Innovation Incubation Base†and “Beijing Bio-pharmaceutical Industry Base†to land in Beijing, and obtained more than 86 million yuan of funds.
The reporter also learned that the “Biomedical Achievement Station†initiated by the Municipal Science Committee is actively introducing and transforming a number of international high-level projects, keeping a close eye on the “high-yielding†scientists centrally located in Beijing’s scientific research institutions and realizing the implementation of a number of major projects. Has already brought together 1,102 valuable achievements at home and abroad. (Next to second edition)
(Continued from the first edition.) Among them, 34 major achievements such as Sanofi Pasteur’s “human diploid cell rabies vaccine†and the Chinese Academy of Medical Sciences Institute of Materia Medica’s “Morphoxa total alkaloids†have successfully landed in Beijing. . After these results are put into production, it is expected that the new output value of Beijing Bio-pharmaceutical Industry will be 6 billion yuan.
Last year, the municipal government launched the G20 project and planned to implement the first phase project from 2010 to 2012. It will achieve the goal of 2012 Beijing biopharmaceutical industry sales exceeding 100 billion yuan; the second phase project will use this for 5 years. The contribution of the bio-pharmaceutical industry to Beijing's GDP was raised to more than 5%, and the bio-pharmaceutical industry was promoted as a pillar industry supporting the economic and social development of the capital.
Last year, the Beijing biopharmaceutical industry realized sales revenue of 55.95 billion yuan, of which biomedical manufacturing industry realized sales revenue of 48.35 billion yuan, and R&D service industry completed income of 7.6 billion yuan. Yesterday, the reporter learned from the Beijing Municipal Science and Technology Commission that at present, 39 G20 (Beijing biomedical industry leap-forward development projects) enterprises have become the core strength of the Beijing biopharmaceutical industry, achieving sales revenue of 24.72 billion yuan from January to November last year alone. It accounts for nearly half of the total industry.
Last year was the year in which Beijing's biopharmaceutical industry straddles development projects. After nearly one year's efforts, the city's biopharmaceutical industry successfully completed its first year's target. At present, the bio-pharmaceutical industry has become an important part of Beijing's economy. Last year alone, the pharmaceutical manufacturing industry achieved an industrial added value of 11.86 billion yuan, ranking fifth in the city's 36 industrial sectors.
In addition, chemical and pharmaceuticals accounted for half of all sub-sectors, and continued to maintain rapid growth. Its main business revenue growth rate of 22%, total profit growth rate of 31%. Among them, the contribution of the Chinese medicine industry has become increasingly prominent. Its total profit growth rate has increased from 4% in 2007 to 20.8% in 2010. Biopharmaceuticals have entered a stage of rapid development, and the main business income has experienced a compound annual growth rate since 2007. It reached 25.1%, and the total annual growth rate of its profit exceeded 41%. Its contribution to the pharmaceutical industry in Beijing has increased year by year, accounting for 21.4% of profits. The contribution in the medical device field has remained stable. The main business income and profits have all accounted for Beijing Pharmaceutical Industry. One-fifth.
As one of the highlights of this project, the Municipal Science and Technology Commission has been committed to docking major national projects and winning major national achievements, projects, and bases in Beijing. Last year, it also won great success in docking the country's "great new drug creation" major science and technology work. According to Yan Aoshuang, director of the Municipal Science and Technology Commission, as of now, the city has undertaken a total of 275 major special projects of science and technology for the country's "major new drug creation" project, and has received funding of 1.81 billion yuan, accounting for 32.9% of the total special funds. At the same time, the city has also successfully implemented two major base projects of “Beijing Bio-pharmaceutical Innovation Incubation Base†and “Beijing Bio-pharmaceutical Industry Base†to land in Beijing, and obtained more than 86 million yuan of funds.
The reporter also learned that the “Biomedical Achievement Station†initiated by the Municipal Science Committee is actively introducing and transforming a number of international high-level projects, keeping a close eye on the “high-yielding†scientists centrally located in Beijing’s scientific research institutions and realizing the implementation of a number of major projects. Has already brought together 1,102 valuable achievements at home and abroad. (Next to second edition)
(Continued from the first edition.) Among them, 34 major achievements such as Sanofi Pasteur’s “human diploid cell rabies vaccine†and the Chinese Academy of Medical Sciences Institute of Materia Medica’s “Morphoxa total alkaloids†have successfully landed in Beijing. . After these results are put into production, it is expected that the new output value of Beijing Bio-pharmaceutical Industry will be 6 billion yuan.
Last year, the municipal government launched the G20 project and planned to implement the first phase project from 2010 to 2012. It will achieve the goal of 2012 Beijing biopharmaceutical industry sales exceeding 100 billion yuan; the second phase project will use this for 5 years. The contribution of the bio-pharmaceutical industry to Beijing's GDP was raised to more than 5%, and the bio-pharmaceutical industry was promoted as a pillar industry supporting the economic and social development of the capital.
Tattoo T-Shirt is just a arm t-shirt which printed with tattoo pattern or tattoo designs. It is a fake tattoo for people who don't really want to do tattoo on their body.
Professional Tattoo T-Shirt Manufacturer in China. Specialize In Manufacturing Wholesale Tattoo Sleeve T-Shirt, Skin Tattoo T-Shirt, Tattoo sleeveless T-shirt, etc products. welcome to come to the consultation.
Tattoo T-Shirt
Tattoo T-Shirt, Tattoo Sleeve T-Shirt, Skin Tattoo T-Shirt, Tattoo sleeveless T-shirt
Amztatto Supply Co., Ltd. , https://www.amztatto.com